Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.
Recall of Marijuana for Medical Purposes - Whistler Medical Marijuana Corp.
- Starting date:
- August 15, 2014
- Posting date:
- August 15, 2014
- Type of communication:
- Information Update
- Source of recall:
- Health Canada
- General Public
- Identification number:
August 15, 2014
For immediate release
OTTAWA – Whistler Medical Marijuana Corp. is voluntarily recalling White Widow batch (Lot L0004) of marijuana for medical purposes. During the course of a regular inspection conducted under the Marihuana for Medical Purposes Regulations, Health Canada inspectors learned the company had received two customer complaints regarding the product’s appearance. The company tested product samples which identified the presence of mould.
Mould does not present a significant risk to healthy Canadians. However, for Canadians whose immune system has been weakened by other serious illnesses, mould could cause infections. Canadians should consult with a healthcare professional if they have concerns about their health related to the use of this product.
Whistler Medical Marijuana Corp. is instructing clients to immediately discontinue use of any marijuana from this batch. Clients should return the marijuana by contacting Whistler Medical Marijuana Corp. to obtain appropriate packaging and postage paid shipping container. If clients wish to destroy the product at home, they should add water to the marijuana to render it unusable, mix it with cat litter to mask the odour and dispose of it with regular household waste.
The company has indicated that it has not received reports of any adverse events associated with the use of this product. Health Canada has not received any reports of adverse reactions associated with the use marijuana supplied by Whistler Medical Marijuana Corp.
Producers of marijuana for medical purposes are subject to compliance and enforcement measures similar to those in place for other producers of controlled substances. They must meet strict security, control and reporting requirements, and they are regularly inspected.
Dried marijuana is not an approved drug or medicine in Canada. Possession and use of marijuana remains illegal in Canada unless authorized under the regulations with the support of a doctor or nurse practitioner.
- 30 -
- Date modified: